Tata India Pharma & Healthcare Fund
In plain words
as of 20 Nov 2026Over 5 years it returned 14.3% a year, above the middle Sectoral / Thematic fund (11.8%) by 2.5 points.
Trailed its benchmark by 2.6 points a year over 5 years (14.3% vs 16.9%).
Its ups and downs have been about typical for its category. Volatility 15.7% vs a category middle of 17.4%.
The deepest fall was −21.9% (Feb 2016 to Jun 2018); it recovered in 624 days.
Of every 1-year period since launch, 33% ended below where they started. The middle 1-year result was 7.3%.
This is a Regular plan: it pays a distributor commission inside its fee. The Direct plan holds the same portfolio at a lower cost.
Key facts
- Fund house
- Tata Mutual Fund
- Category
- Sectoral / Thematic (SEBI)
- Plan & option
- Regular · Growth
- Benchmark i
- NIFTY Pharma TRI (tracked via Nippon India Nifty Pharma ETF - Direct Plan)
- First NAV
- 29 Dec 2015 · 10.9 years of history · 2,684 NAVs
- AMFI code
- 135812
- ISIN
- INF277K016A9
- Expense ratio i
- 2.40%
- Fund size
- Not loaded yet
How ₹100 grew
Returns
Up to 1 year: total change. Longer: yearly (CAGR) i| 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 7Y | 10Y | Since launch | |
|---|---|---|---|---|---|---|---|---|---|---|
| This fund | +9.73% | +0.76% | +6.88% | +12.33% | +10.25% | +17.02% | +14.30% | +20.37% | +14.17% | +11.82% |
| NIFTY Pharma TRI* | +10.85% | +7.49% | +14.67% | +25.66% | +25.86% | +22.31% | +16.87% | — | — | — |
| Sectoral / Thematic middle fund i | +6.83% | +0.56% | +8.02% | +3.99% | +3.08% | +13.34% | +11.84% | +16.65% | +14.59% | — |
Category middle = median Regular Growth fund in Sectoral / Thematic (145 funds with 3 years). * Benchmark approximated by Nippon India Nifty Pharma ETF - Direct Plan with its expense ratio added back. Blank means not enough history, never zero.
Risk and risk-adjusted return
Last 36 months · risk-free rate 6.5%Against its benchmark
NIFTY Pharma TRI · 36 monthly returnsThe worst it has been
Every 1-year period i
One 5-year number depends on its start date. These show what happened across every start date in the fund's life.
What it holds
Against similar funds
Top Sectoral / Thematic Regular Growth funds by return. A sort by one past number, not a recommendation.
| Fund | Return | Volatility | Sharpe | Alpha | Beta | Deepest fall | Stars |
|---|---|---|---|---|---|---|---|
| HDFC Defence Fund HDFC | +29.97% | 30.9% | 0.76 | — | — | −35.01% | ★★★★★ |
| Nippon India Taiwan Equity Fund Nippon India | +29.29% | 42.3% | 0.54 | +29.47% | −0.13 | −47.41% | ★★★★★ |
| HDFC Pharma and Healthcare Fund HDFC | +29.16% | 15.8% | 1.44 | +6.36% | 0.97 | −15.07% | ★★★★★ |
| SBI HEALTHCARE OPPORTUNITIES FUND SBI | +23.51% | 14.1% | 1.21 | +4.17% | 0.86 | −63.37% | ★★★★★ |
| HDFC Transportation and Logistics Fund HDFC | +22.99% | 19.1% | 0.86 | +10.05% | 1.02 | −23.97% | ★★★★★ |
| Mirae Asset Healthcare Fund Mirae Asset | +22.24% | 15.5% | 1.02 | +1.86% | 0.96 | −20.09% | ★★★★★ |
| UTI - Healthcare Fund UTI | +22.05% | 15.3% | 1.01 | +2.15% | 0.91 | −33.91% | ★★★★★ |
| Aditya Birla Sun Life Transportation and Logistics Fund ABSL | +21.45% | 19.9% | 0.75 | +8.23% | 1.09 | −28.78% | Not rated |
| ICICI PRUDENTIAL TRANSPORTATION AND LOGISTICS FUND ICICI Pru | +21.37% | 18.9% | 0.79 | +8.29% | 1.06 | −24.03% | ★★★★★ |
| ICICI Prudential Healthcare Fund ICICI Pru | +20.77% | 15.5% | 0.92 | +1.11% | 0.92 | −20.72% | ★★★★★ |
| Tata India Pharma & Healthcare Fund Tata | +17.02% | 15.7% | 0.67 | −4.21% | 1.00 | −21.94% | ★★★★★ |
Compare side by side with another Sectoral / Thematic fund
If you had run a SIP i
₹10,000 on the first NAV of every month for 5 years: ₹6,00,000 invested would be worth ₹9,09,680 on 20 Nov 2026.
XIRR counts each instalment for the time it was invested, so it is the return a SIP investor actually got.
Try your own amount and datesAll plans and options
| Scheme | NAV | AMFI code |
|---|---|---|
| Direct · Growth | ₹40.2296 | 135810 |
| Direct · IDCW | ₹38.9215 | 135807 |
| Direct · IDCW | ₹38.9215 | 135808 |
| Regular · Growth | ₹33.9323 | 135812 |
| Regular · IDCW | ₹32.6347 | 135809 |
| Regular · IDCW | ₹32.6347 | 135811 |
About Sectoral / Thematic funds
- The rule
- At least 80% in one sector (banking, pharma, IT ...) or theme (consumption, manufacturing ...).
- Who it can suit
- Investors adding a deliberate bet on top of a diversified core.
- Typical holding period
- 7 years or more
Questions people ask
What is the NAV of Tata India Pharma & Healthcare Fund?
₹33.9323 as of 20 Nov 2026, from AMFI's daily NAV file. NAVs are published once every business day after markets close.
Direct or Regular: what is the difference?
Same portfolio. Regular pays a distributor commission inside its fee, so it returns a little less every year.
Growth or IDCW?
Growth reinvests everything. IDCW pays some out, so its NAV drops after each payout and its NAV-based return understates what investors received.
How are these numbers calculated?
Every figure is computed by Growth from the fund's published NAV history. See How we calculate.